Chris Obrien - 08 Feb 2023 Form 4 Insider Report for C. H. ROBINSON WORLDWIDE, INC. (CHRW)

Reporting relationship: Chief Commercial Officer
Issuer ticker: CHRW
Reported as of: 08 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Feb 2023, 15:32:53 UTC
Prior SEC filing: 03 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Jessica Homes, Attorney-in-Fact for Chris O'Brien

Key filing fact

Chris Obrien filed Form 4 for C. H. ROBINSON WORLDWIDE, INC. (CHRW) on 10 Feb 2023.

Key facts

This page summarizes Chris Obrien's Form 4 filing for C. H. ROBINSON WORLDWIDE, INC. (CHRW).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 10 Feb 2023, 15:32.

Change

Previous filing in this sequence was filed on 03 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CHRW transaction

Common Stock

Award

Transaction value: $0
Shares: +1,940
Change %: +2.6%
Price: $0.000000
Shares after: 77,805
Date: 08 Feb 2023
Ownership: Direct
Footnotes: F1

CHRW transaction

Common Stock

Award

Transaction value: $0
Shares: +2,226
Change %: +2.9%
Price: $0.000000
Shares after: 80,031
Date: 08 Feb 2023
Ownership: Direct
Footnotes: F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Chris Obrien is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Restricted stock units vest ratably over a 3 year period between January 1, 2023 and December 31, 2025.

Footnote F2

Represents Performance-based restricted stock units that vested on February 8, 2023, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

Footnote F3

Included in this amount are 79,798 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares and restricted stock units credited to the reporting person's NQDC Plan account.

Footnote F4

Includes 233 shares acquired pursuant to the Issuer's employee stock purchase plan.